Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...
Nafisa Ali has shared a deeply personal health update, posting an image of her abdominal surgical scar—calling it her “great ...
A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with KRAS G12C–mutated metastatic colorectal cancer (CodeBreaK 301). This ...
In this video, Ursula A. Matulonis, MD, discusses a study assessing letrozole alone compared with standard chemotherapy followed by letrozole maintenance in patients with low-grade serous ovarian, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results